Meet ApplyKite Twin, the application assistant that learns with you

Meet your Twin, it learns with you

Your Twin learns with you

Launch week codes:30% off annual Pro20% off monthly Pro

Ends in00h00m00s

Elizabeth Christie

Peter MacCallum Cancer Institute

Australia

Research Interests

Explore related searches

Professors in Australia Professors in Immunology Immunology professors in Australia

Articles (20)

Year:

2025

Year:

2025

Year:

2025

Year:

2025

Year:

2025

Year:

2024

Year:

2024

Year:

2023

Year:

2023

Year:

2023

Year:

2023

Year:

2023

Year:

2023

Year:

2023

Year:

2023

Year:

2023

Year:

2023

Year:

2023

Year:

2023

Year:

2023

Collaborators (37)

Andrew Redfern

University of Western Australia

AUSTRALIA

View details

Brian Stramer

Reader

King's College London - Guy's Campus

UNITED KINGDOM

View details

Naoto Ueno

Professor of Medicine

University of Hawai'i Cancer Center

UNITED STATES

View details

Robin Anderson

Head

La Trobe University

AUSTRALIA

View details

Michelle Tate

Group Leader

MONASH UNIVERSITY

AUSTRALIA

View details

Marion Curtis

Associate Professor

Mayo Clinic Arizona

UNITED STATES

View details

Wendy Rathmell

Professor, Department Chair

Vanderbilt University Medical Center

UNITED STATES

View details

Lara Urban

Principal Investigator

Helmholtz Zentrum München Deutsches Forschungszentrum für Umwelt und Gesundheit

GERMANY

View details

Matthew Wakefield

University of Melbourne

AUSTRALIA

View details

Akhilesh Pandey

Professor

Mayo Clinic Rochester

UNITED STATES

View details

Ville Mustonen

University of Helsinki

FINLAND

View details

Olga Kondrashova

Team Head, Molecular Oncology

QIMR Berghofer Medical Research Institute

AUSTRALIA

View details

Daniel Brewer

Professor of Medical Bioinformatics and Genomics

University of East Anglia

UNITED KINGDOM

View details

Edward Curry

Imperial College London

UNITED KINGDOM

View details

Seong Gu Heo

Dana-Farber Cancer Institute

UNITED STATES

View details

David Adams

Senior Group Leader (and Interim Programme Head)

Wellcome Sanger Institute

UNITED KINGDOM

View details

Francisco G Rodriguez Gonzalez

Københavns Universitet

DENMARK

View details

Dale Garsed

University of Melbourne

AUSTRALIA

View details

Maxime Tarabichi

Université libre de Bruxelles

BELGIUM

View details

David Wedge

The University of Manchester

UNITED KINGDOM

View details

Nollaig Bourke

Assistant Professor in Inflammaging

Trinity College Dublin

IRELAND

View details

Lisa Spalding

University of Western Australia

AUSTRALIA

View details

Paul Pharoah

Professor of Cancer Epidemiology

Cedars-Sinai Medical Center

UNITED STATES

View details

Elaine Sanij

St Vincent's Institute of Medical Research

AUSTRALIA

View details

qiang pan-hammarstrom

Professor, head of the Immunology Division

Karolinska University Hospital

SWEDEN

View details

Matthew Fittall

Honorary Associate Professor

University College London

UNITED KINGDOM

View details

Besaiz J. Sánchez-Sánchez

King’s College London

UNITED KINGDOM

View details

Ken Chen

The University of Texas MD Anderson Cancer Center

UNITED STATES

View details

Samantha Bersani

University of Verona

ITALY

View details

Le Ying

MONASH UNIVERSITY

AUSTRALIA

View details

Jingky Lozano-Kuehne

Lecturer in Biostatistics

Newcastle University

UNITED KINGDOM

View details

Clare Scott

Walter and Eliza Hall Institute of Medical Research

AUSTRALIA

View details

Anke Katharina Bergmann

Director, Chair

University Hospital Würzburg

GERMANY

View details

Susan Ramus

Professor of Molecular Oncology

University of New South Wales

AUSTRALIA

View details

Callum Dark

Teaching Assistant

Monash University Malaysia.

AUSTRALIA

View details

Young Seok Ju

Associate Professor

Korea Advanced Institute of Science and Technology

SOUTH KOREA

View details

Gwo Yaw Ho

Head of Cancer Immunology Laboratory

MONASH UNIVERSITY

AUSTRALIA

View details

ApplyKite TwinLearns as you apply

Make your next move.

Prepare your application

Review drafts before you send them.

Elizabeth Christie

Research Interests

Explore related searches

Articles (20)

Crowd-sourced benchmarking of single-sample tumor subclonal reconstruction

Immunogenic cryptic peptides dominate the antigenic landscape of ovarian cancer

Exploiting dysregulated iron homeostasis to eradicate persistent high-grade serous ovarian cancer.

Biology of ovarian cancer: Models, microenvironment, and therapeutics: 15th Biennial Rivkin Center Ovarian Cancer Research Symposium.

Genome doubling fuels ovarian cancer evolution and immune dysregulation

Concurrent RB1 Loss and BRCA Deficiency Predicts Enhanced Immunologic Response and Long-term Survival in Tubo-ovarian High-grade Serous Carcinoma.

Timing of whole genome duplication is associated with tumor-specific MHC-II depletion in serous ovarian cancer

Estrogen receptor beta expression in triple negative breast cancers is not associated with recurrence or survival

Interferon-ε is a tumour suppressor and restricts ovarian cancer

Author Correction: The landscape of viral associations in human cancers

Author Correction: Pan-cancer analysis of whole genomes.

Author Correction: Comprehensive molecular characterization of mitochondrial genomes in human cancers

Author Correction: Pan-cancer analysis of whole genomes identifies driver rearrangements promoted by LINE-1 retrotransposition

Convergent insulin and TGF‐β signalling drives cancer cachexia by promoting aberrant fat body ECM accumulation in a Drosophila tumour model

The microtubule inhibitor eribulin demonstrates efficacy in platinum-resistant and refractory high-grade serous ovarian cancer patient-derived xenograft models

Author Correction: Disruption of chromatin folding domains by somatic genomic rearrangements in human cancer (Nature Genetics, (2020), 52, 3, (294-305), 10.1038/s41588-019-0564-y)

Author Correction: Comprehensive analysis of chromothripsis in 2,658 human cancers using whole-genome sequencing (Nature Genetics, (2020), 52, 3, (331-341), 10.1038/s41588-019-0576-7)

Spatial and temporal intra-tumoral heterogeneity in advanced HGSOC: Implications for surgical and clinical outcomes

Multiomic analysis of homologous recombination-deficient end-stage high-grade serous ovarian cancer

Small-scale mutations are infrequent as mechanisms of resistance in post-PARP inhibitor tumour samples in high grade serous ovarian cancer.

Collaborators (37)

Andrew Redfern

Brian Stramer

Naoto Ueno

Robin Anderson

Michelle Tate

Marion Curtis

Wendy Rathmell

Lara Urban

Matthew Wakefield

Akhilesh Pandey

Ville Mustonen

Olga Kondrashova

Daniel Brewer

Edward Curry

Seong Gu Heo

David Adams

Francisco G Rodriguez Gonzalez

Dale Garsed

Maxime Tarabichi

David Wedge

Nollaig Bourke

Lisa Spalding

Paul Pharoah

Elaine Sanij

qiang pan-hammarstrom

Matthew Fittall

Besaiz J. Sánchez-Sánchez

Ken Chen

Samantha Bersani

Le Ying

Jingky Lozano-Kuehne

Clare Scott

Anke Katharina Bergmann

Susan Ramus

Callum Dark

Young Seok Ju

Gwo Yaw Ho

Make your next move.